Luciano Frontini

Pretreatment Quality of Life and Functional Status Assessment Significantly Predict Survival of Elderly Patients With Advanced Non—Small-Cell Lung Cancer Receiving Chemotherapy: A Prognostic Analysis of the Multicenter Italian Lung Cancer in the Elderly Study

Paolo Maione, Francesco Perrone, Ciro Gallo et al. · Journal of Clinical Oncology · 2005 · 477 citations · Full text

Medicine, Geriatric Medicine, Oncology +17

Gemcitabine Plus Vinorelbine Compared With Cisplatin Plus Vinorelbine or Cisplatin Plus Gemcitabine for Advanced Non–Small-Cell Lung Cancer: A Phase III Trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group

Cesare Gridelli, Ciro Gallo, Frances A. Shepherd et al. · Journal of Clinical Oncology · 2003 · 245 citations

Medicine, Oncology, Pharmacology +11

Prediction of survival of patients terminally III with cancer. Results of an Italian prospective multicentric study

Marco Maltoni, M Pirovano, Emanuela Scarpi et al. · Cancer · 1995 · 197 citations · Full text

Medicine, Oncology, Palliative Medicine +14

Activity and toxicity of gemcitabine and gemcitabine+vinorelbine in advanced non-small-cell lung cancer elderly patients

Cesare Gridelli, S. Cigolari, Ciro Gallo et al. · Lung Cancer · 2001 · 129 citations

Medicine, Oncology, Pharmacology +10

Incidence and clinical implications of venous thromboembolism in advanced colorectal cancer patients: The ‘GISCAD-alternating schedule’ study findings

Mario Mandalà, Sandro Barni, Irene Floriani et al. · European Journal of Cancer · 2008 · 57 citations

Medicine, Hematology, Oncology +16